^
    CANCER:
    Giant Cell Tumor of Bone
    No biomarker
    Giant Cell Tumor of Bone
    denosumab
    Sensitive
    :
    A1
    No biomarker
    Tenosynovial Giant Cell Tumor
    pexidartinib
    Sensitive
    :
    A1
    No biomarker
    Chordoma
    sorafenib
    Sensitive
    :
    A2
    No biomarker
    Chordoma
    dasatinib
    Sensitive
    :
    A2
    No biomarker
    Chordoma
    YD312
    Sensitive
    :
    A2
    No biomarker
    Chordoma
    sunitinib
    Sensitive
    :
    A2
    No biomarker
    Chordoma
    erlotinib
    Sensitive
    :
    A2
    TMB-H
    Chordoma
    pembrolizumab
    Sensitive
    :
    A2
    EGFR expression
    Chordoma
    lapatinib
    Sensitive
    :
    A2
    MSI-H/dMMR
    Chordoma
    pembrolizumab
    Sensitive
    :
    A2
    SMARCB1 negative
    Chordoma
    tazemetostat
    Sensitive
    :
    C2
    PTEN deletion
    Chordoma
    PDGFR inhibitor
    Resistant
    :
    C4
    PTEN deletion
    Chordoma
    PDGFR inhibitor + HDAC inhibitor
    Sensitive
    :
    C4
    H3F3A mutation + ARID2 mutation
    Giant Cell Tumor of Bone
    denosumab
    Resistant
    :
    C4
    AXL underexpression
    Chordoma
    afatinib
    Sensitive
    :
    D
    STK33 underexpression
    Chordoma
    afatinib
    Sensitive
    :
    D
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES